 |
|
Disease diagnosis in just 15 minutes
October 02, 2008Testing for diseases such as cancer and multiple sclerosis could soon be as simple as using a pregnancy testing kit.
A team led by scientists at the University of Leeds has developed a biosensor technology that uses antibodies to detect biomarkers - molecules in the human body which are often a marker for disease - much faster than current testing methods.
The technology could be used in doctors' surgeries for more accurate referral to consultants, and in hospitals for rapid diagnosis. Tests have shown that the biosensors can detect a wide range of analytes (substances being measured), including biomarkers present in prostate and ovarian cancer, stroke, multiple sclerosis, heart disease and fungal infections. The team also believes that the biosensors are versatile enough to test for diseases such as tuberculosis and HIV.
The technology was developed through a European collaboration of researchers and commercial partners in a 2.7 million Euro project called ELISHA. It features new techniques for attaching antibodies to innovative surfaces, and novel electronic measurement methods that need no reagents or labels.
ELISHA was co-ordinated by Dr Paul Millner from the Faculty of Biological Sciences at the University of Leeds, and managed by colleague Dr Tim Gibson. Says Dr Millner: "We believe this to be the next generation diagnostic testing. We can now detect almost any analyte faster, cheaper and more easily than the current accepted testing methodology."
Currently blood and urine are tested for disease markers using a method called ELISA (Enzyme Linked Immunosorbant Assay). Developed in the 1970s, the process takes an average of two hours to complete, is costly and can only be performed by highly trained staff.
The Leeds team are confident their new technology - which provides results in 15 minutes or less - could be developed into a small device the size of a mobile phone into which different sensor chips could be inserted, depending on the disease being tested for.
"We've designed simple instrumentation to make the biosensors easy to use and understand," says Dr Millner. "They'll work in a format similar to the glucose biosensor testing kits that diabetics currently use."
Professor Séamus Higson, Dean of the Faculty of Medicine and Biosciences, Cranfield Health, and one of the partners within the ELISHA programme, says: "The speed of response this technology offers will be of great benefit to early diagnosis and treatment of many diseases, and will permit testing in de-localised environments such as GP's surgeries."
A spinout company - ELISHA Systems Ltd - has been set up by Dr Gibson, commercial partners Uniscan Instruments Ltd and Technology Translators Ltd to bring the technology to market.
Says Dr Gibson: "The analytes used in our research only scratch the surface of the potential applications. We've also shown that it can be used in environmental applications, for example to test for herbicides or pesticides in water and antibiotics in milk."
University of Leeds
The technology was developed through a European collaboration of researchers and commercial partners in a 2.7 million Euro project called ELISHA. It features new techniques for attaching antibodies to innovative surfaces, and novel electronic measurement methods that need no reagents or labels.
ELISHA was co-ordinated by Dr Paul Millner from the Faculty of Biological Sciences at the University of Leeds, and managed by colleague Dr Tim Gibson. Says Dr Millner: "We believe this to be the next generation diagnostic testing. We can now detect almost any analyte faster, cheaper and more easily than the current accepted testing methodology."
Currently blood and urine are tested for disease markers using a method called ELISA (Enzyme Linked Immunosorbant Assay). Developed in the 1970s, the process takes an average of two hours to complete, is costly and can only be performed by highly trained staff.
The Leeds team are confident their new technology - which provides results in 15 minutes or less - could be developed into a small device the size of a mobile phone into which different sensor chips could be inserted, depending on the disease being tested for.
"We've designed simple instrumentation to make the biosensors easy to use and understand," says Dr Millner. "They'll work in a format similar to the glucose biosensor testing kits that diabetics currently use."
Professor Séamus Higson, Dean of the Faculty of Medicine and Biosciences, Cranfield Health, and one of the partners within the ELISHA programme, says: "The speed of response this technology offers will be of great benefit to early diagnosis and treatment of many diseases, and will permit testing in de-localised environments such as GP's surgeries."
A spinout company - ELISHA Systems Ltd - has been set up by Dr Gibson, commercial partners Uniscan Instruments Ltd and Technology Translators Ltd to bring the technology to market.
Says Dr Gibson: "The analytes used in our research only scratch the surface of the potential applications. We've also shown that it can be used in environmental applications, for example to test for herbicides or pesticides in water and antibiotics in milk."
University of Leeds
Disease Diagnosis Current Events and Disease Diagnosis News RSSLow level cadmium exposure linked to lung disease
New research suggests that cadmium is one of the critical ingredients causing emphysema, and even low-level exposure attained through second-hand smoke and other means may also increase the chance of developing lung disease.
Subtle nervous system abnormalities appear to predict risk of death in older individuals
Subtle but clinically detectable neurological abnormalities, such as reduced reflexes and an unstable posture, may be associated with the risk of death and stroke in otherwise healthy older adults, according to a report in the June 23 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
OHSU Discovery May Lead to Early Cancer Detection
OHSU pancreatic cancer expert Brett Sheppard, M.D., and colleagues in the OHSU Oregon Stem Cell Center, have developed antibodies that recognize pancreatic cancer; Sheppard is presenting these findings this week during Digestive Disease Week in San Diego.
Spit tests may soon replace many blood tests
One day soon patients may spit in a cup, instead of bracing for a needle prick, when being tested for cancer, heart disease or diabetes. A major step in that direction is the cataloguing of the "complete" salivary proteome, a set of proteins in human ductal saliva, identified by a consortium of three research teams.
Toward the ethical treatment of whole genome research participants
Recent technological developments have made it possible for scientists to sequence an entire human genome, but these advances may be a mixed blessing.
Carnegie Mellon scientist uses mass spectrometer to weigh virus particle, von Willebrand factor
With unprecedented sensitivity, Carnegie Mellon University's Mark Bier has characterized large viral particles and bulky von Willebrand factors using a novel mass spectrometer.
Why bad things can happen to the heart when 'good' cholesterol goes bad
It's yet another example of how a good thing can go bad: Researchers have found evidence in laboratory studies that 'good' cholesterol, renowned for its ability to protect against heart disease, can undergo detrimental changes in protein composition that make it 'bad' for the heart.
Smoking associated with lower Parkinson's disease risk
A pooled analysis of data from previous studies suggests that cigarette smoking appears to be associated with a reduced risk for developing Parkinson's disease, with long-term and current smokers at the lowest risk.
Depression often untreated in Parkinson's disease patients
While depression appears to be common in early Parkinson's disease (PD), it is often not treated or diagnosed, according to newly released research.
New NIST reference material for peptide analysis
The National Institute of Standards and Technology (NIST) has issued its first-ever reference material designed to improve the performance and reliability of experiments to measure the masses and concentrations of peptides in biomolecular samples.
More Disease Diagnosis Current Events and Disease Diagnosis News Articles
 | Laboratory Diagnosis of Infectious Diseases: Essentials of Diagnostic Microbiology by Paul G Engelkirk, Janet Duben-Engelkirk Designed for associate-degree MLT/CLT programs and baccalaureate MT/CLS programs, this textbook presents the essentials of clinical microbiology. It provides balanced coverage of specific groups of microorganisms and the work-up of clinical specimens by organ system, and also discusses the role of the microbiology laboratory in regard to emerging infections, healthcare epidemiology, and... |
 | Fish Disease: Diagnosis and Treatment by Edward J. Noga North Carolina State Univ., Raleigh. Reprint of an original Mosby-Year Book edition, c1996. Intended to guide the reader through commonly encountered fish diseases and to provide the knowledge to management these diseases effectively. Focus is on cultured fish, but data also applies to wild populations. Color and halftone... |
 | Skin Disease: Diagnosis and Treament by Thomas P. Habif, James L. Campbell Jr., M. Shane Chapman, James G. H. Dinulos, Kathryn A. Zug Specifically designed for quick reference, this full-color resource focuses on the 250 diseases most likely seen in everyday practice. The revised and updated 2nd Edition features practical, clear advice on diagnosis and therapy, and includes anterior and posterior diagrams of where diseases may be found on the body as well as classifications of primary, secondary, and special lesions. Over 700... |
 | Clinical Dermatology: A Color Guide to Diagnosis and Therapy by Thomas P. Habif Completely revised and updated, the 4th Edition of this popular reference presents a wealth of new features to enable readers to identify, treat, and manage skin diseases more easily than ever. Atlas-like guidance, complemented with detailed, diagnostic text, combine to offer readers a user-friendly resource they'll consult again and again. Also available as a separate website and e-dition... |
 | The Wills Eye Manual: Office and Emergency Room Diagnosis and Treatment of Eye Disease (Rhee, The Wills Eye Manual) Now in full color and completely updated, the Fifth Edition of this best-selling manual is a reliable quick-reference guide for all clinicians who treat eye disorders. Every disorder encountered in the office, emergency room, or hospital is covered in concise outline format: symptoms, signs, work-up, treatment, and follow-up. Also included are chapters on differential diagnosis of ocular symptoms... |
 | Current Diagnosis & Treatment in Infectious Diseases by Walter Wilson, Merle Sande Internationally renowned infectious disease experts offer guidance in recognizing, diagnosing, treating, and preventing one of the leading causes of death worldwide. Clinically focused and comprehensive, the book covers the essentials of diagnosis and syndromes in children and adults. Examines antimicrobial resistance and balances expert, practice-oriented coverage with just the right amount of... |
 | Pediatric Gastrointestinal Disease (Pediatric Gastrointestinal Disease: Pathology, Diagnosis, Ma) by Kleinman The revision of this definitive reference work (in two volumes) is dedicated to the maintenance of a comprehensive approach to the practice of Paediatric Gastroenterology. The text of the fifth edition was extensively reviewed to assess the continuing relevance and as a result, the size and content of various sections have been modified and new chapters have been added. Each author, selected... |
 | Diagnosis and Management of Adult Congenital Heart Disease by Michael A. Gatzoulis, Gary D. Webb, Piers E. F. Daubeney This practical resource provides essential guidance on the anatomic issues, clinical presentation, diagnosis, and clinical management of adults with congenital heart disease. Each consistently structured, disease-oriented chapter discusses incidence, genetics, morphology, presentation, investigation and imaging, treatment, and intervention. A wealth of illustrationsincluding line drawings, EKGs,... |
 | Current Diagnosis And Treatment of Sexually Transmitted Diseases by Jeffrey Klausner, III,Edward Hook Get problem-oriented and disease-specific guidance in treating STDs-in one quick-access source. . Featuring the trusted, practical format of the CURRENT series, this authoritative, quick-access guide delivers a top-to-bottom overview of STDs commonly encountered in clinical practice. The book begins with an insightful introduction to the field that emphasizes the patient-doctor relationship,... |
 | Fraser and Pare's Diagnosis of Diseases of the Chest (4 Volume set) by Richard S. Fraser, Nestor L. Muller, Neil C. Colman, P. D. Pare McGill Univ., Montreal, Canada. Clinical texts based on consideration of specific diseases and includes: epidemiology, etiology and pathogenesis, pathologic characteristics, radiologic and clinical manifestations, laboratory findings, and prognosis and natural history. Does not include treatment. Previous edition: c1988. Abundant halftone illustrations. DNLM: Thoracic... |
| © 2009 BrightSurf.com |